Percheron Therapeutics Limited (ASX:PER)
Australia · Delayed Price · Currency is AUD 0.0070
0.00 (0.00%)
Mar 4, 2026, 2:06 PM AEST
Percheron Therapeutics Market Cap
Percheron Therapeutics has a market cap or net worth of 7.61 million as of March 4, 2026. Its market cap has decreased by -12.50% in one year.
Market Cap
7.61M
Enterprise Value
3.17M
Revenue
1.74M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since December 20, 2001, Percheron Therapeutics's market cap has decreased from 26.10M to 7.61M, a decrease of -70.83%. That is a compound annual growth rate of -4.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 7.61M | -22.22% |
| Dec 31, 2025 | 9.79M | 28.57% |
| Dec 31, 2024 | 7.61M | -85.69% |
| Dec 29, 2023 | 53.19M | -18.04% |
| Dec 30, 2022 | 64.90M | -50.23% |
| Dec 31, 2021 | 130.40M | 74.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Little Green Pharma | 33.64M |
| Vitura Health | 27.84M |
| IDT Australia | 21.37M |
| Peak Processing | 20.86M |
| Cann Group | 12.71M |
| Epsilon Healthcare | 10.51M |
| ECS Botanics Holdings | 9.58M |
| Invion | 6.77M |